Term ends May 15, 2044 · Medium confidence
20-year base term ends May 15, 2044
Why Medium: A parent in the chain could not be resolved.
Held by Nchroma Bio, Inc.
Filed Jul 2, 2024 as application 18/762,259 · Granted Aug 19, 2025
Base term, 20 years from filing
Today
2024
2044
Clock starts
May 15, 2024
May 15, 2024
Term ends
May 15, 2044
May 15, 2044
Granted
Aug 19, 2025
Aug 19, 2025
base term
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 15, 2024, when application PCT/US2024/029529, the earliest non-provisional in its chain, was filed (this one was filed Jul 2, 2024); a parent in its chain could not be resolved (the next row) | May 15, 2044 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 15, 2044 | Medium confidence |
This family
| Application PCT/US2024/029529 | PCT application no patent term | no patent term |
| US 12,558,437 | In force May 2044 | May 2044 |
| US 12,390,538 | this patent May 2044 | May 2044 |
| US 12,649,003 | In force May 2044 | May 2044 |
| Application 19/390,246 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 29, 2025 Reel 70971, frame 188 | Anglero-rodriguez, Yesseinia | Chroma Medicine, Inc. | Assignment of Assignor's Interest |
| Apr 29, 2025 Reel 70971, frame 197 | Jaffe, Aaron Brandon | Chroma Medicine, Inc. | Assignment of Assignor's Interest |
| Apr 29, 2025 Reel 70972, frame 17 | Abubucker, Noorussahar | Chroma Medicine, Inc. | Assignment of Assignor's Interest |
| Apr 29, 2025 Reel 70972, frame 83 | Lombardo, Angelo Leone; Cappelluti, Martino Alfredo | Fondazione Telethon; Ospedale San Raffaele S.R.L. | Assignment of Assignor's Interest |
| Apr 29, 2025 Reel 70972, frame 92 | Myer, Vic | Chroma Medicine, Inc. | Assignment of Assignor's Interest |
| Apr 29, 2025 Reel 70972, frame 122 | Fondazione Telethon; Ospedale San Raffaele S.R.L. | Epsilen Bio S.R.L. | Assignment of Assignor's Interest |
| Apr 29, 2025 Reel 70975, frame 297 | Epsilen Bio S.R.L. | Chroma Medicine, Inc. | Assignment of Assignor's Interest |
| Apr 29, 2025 reel/frame not recorded | Cappelluti, Martino Alfredo; Lombardo, Angelo Leone | Fondazione Telethon | Assignment of Assignor's Interest |
| Apr 29, 2025 reel/frame not recorded | Cappelluti, Martino Alfredo; Lombardo, Angelo Leone | Ospedale San Raffaele S.R.L. | Assignment of Assignor's Interest |
| Apr 30, 2025 Reel 70990, frame 395 | Chroma Medicine, Inc. | Nchroma Bio, Inc. | Change of Name |
| Jun 4, 2025 Reel 71535, frame 158 | Chroma Medicine, Inc. | Nchroma Bio, Inc. | Corrective Assignment to Correct the Conveyance Type Previously Recorded on Reel 70990 Frame 395. Assignor(S) Hereby Confirms the Merger and Change of Name. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
May 2044
Term ends May 15, 2044. Maintenance fees still fall due before then
Citations
0
later US patents cite this one
Fewer than half of the utility patents granted in 2025 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.